Loading...

Sarah Sheibani, MD

Title(s)Assistant Professor of Clinical Medicine
Phone+1 323 442 5576
vCardDownload vCard

    Collapse Biography 
    Collapse Awards and Honors
    Golden Key National Honor Society1997Member
    Scholastic Honor Society2000Member
    2000Robert Ernst Prize for Excellence in Research in the Biological Sciences
    Phi Beta Kappa2000Elected Member
    University of California, Irvine2001Regent's Scholarship
    2004  - 2005Gold Headed Cane Award for Devotion to Patient Care
    Gold Humanism Honor Society2005Member
    Alpha Omega Alpha2005Elected Member
    Stanford University2006Franklin G. Ebaugh Jr. Award for Resident Research

    Collapse Overview 
    Collapse Overview
    Dr. Sheibani is a gastroenterologist with specialized training in inflammatory bowel diseases (IBD). She completed her internship and residency training in internal medicine at Stanford University. Following her Gastroenterology Fellowship at USC, she did an extra year of training in IBD at the University of California, San Francisco. Dr. Sheibani’s research interests include the treatment of gastrointestinal bleeding and health-care maintenance issues in patients with IBD.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Zhang B, Naomi Nakamura B, Perlman A, Alipour O, Abbasi SQ, Sohn P, Gulati A, Moore G, Hwang C, Sheibani S, Zarchy T, Shao L. Identification of functional missense single-nucleotide polymorphisms in TNFAIP3 in a predominantly Hispanic population. J Clin Transl Sci. 2018 12; 2(6):350-355. PMID: 31131138.
      View in: PubMed
    2. Mao EJ, Sheibani S, Martin C, Bloomfeld RS, Isaacs K, Saha S, Mahadevan U. Preventive Health Care Among Postpartum Women With Inflammatory Bowel Disease: Results From the PIANO Registry. Inflamm Bowel Dis. 2019 03 14; 25(4):797-802. PMID: 30256951.
      View in: PubMed
    3. Hosseini S, Naderi-Manesh H, Vali H, Baghaban Eslaminejad M, Azam Sayahpour F, Sheibani S, Faghihi S. Contribution of osteocalcin-mimetic peptide enhances osteogenic activity and extracellular matrix mineralization of human osteoblast-like cells. Colloids Surf B Biointerfaces. 2019 Jan 01; 173:662-671. PMID: 30368214.
      View in: PubMed
    4. Serpooshan V, Sheibani S, Pushparaj P, Wojcik M, Jang AY, Santoso MR, Jang JH, Huang H, Safavi-Sohi R, Haghjoo N, Nejadnik H, Aghaverdi H, Vali H, Kinsella JM, Presley J, Xu K, Yang PC, Mahmoudi M. Effect of Cell Sex on Uptake of Nanoparticles: The Overlooked Factor at the Nanobio Interface. ACS Nano. 2018 03 27; 12(3):2253-2266. PMID: 29536733.
      View in: PubMed
    5. Sheibani S, Mohammadi-Sangcheshmeh A, Alamouti AA, Khadem AA, Norouzian MA. Metabolic and molecular responses to calcium soap of fish oil fed to ewes during peripartal period. Cell Mol Biol (Noisy-le-grand). 2017 10 31; 63(10):4-10. PMID: 29096739.
      View in: PubMed
    6. Hajipour MJ, Ghasemi F, Aghaverdi H, Raoufi M, Linne U, Atyabi F, Nabipour I, Azhdarzadeh M, Derakhshankhah H, Lotfabadi A, Bargahi A, Alekhamis Z, Aghaie A, Hashemi E, Tafakhori A, Aghamollaii V, Mashhadi MM, Sheibani S, Vali H, Mahmoudi M. Sensing of Alzheimer's Disease and Multiple Sclerosis Using Nano-Bio Interfaces. J Alzheimers Dis. 2017; 59(4):1187-1202. PMID: 28759965.
      View in: PubMed
    7. Sheibani S, Laine L. Reply. Hepatology. 2017 04; 65(4):1416-1417. PMID: 27783417.
      View in: PubMed
    8. Latifi N, Heris HK, Thomson SL, Taher R, Kazemirad S, Sheibani S, Li-Jessen NY, Vali H, Mongeau L. A Flow Perfusion Bioreactor System for Vocal Fold Tissue Engineering Applications. Tissue Eng Part C Methods. 2016 09; 22(9):823-38. PMID: 27537192.
      View in: PubMed
    9. Sheibani S, Khemichian S, Kim JJ, Hou L, Yan AW, Buxbaum J, Dara L, Laine L. Randomized trial of 1-week versus 2-week intervals for endoscopic ligation in the treatment of patients with esophageal variceal bleeding. Hepatology. 2016 08; 64(2):549-55. PMID: 27082942.
      View in: PubMed
    10. Sheibani S, Cohen R, Kane S, Dubinsky M, Church JA, Mahadevan U. The Effect of Maternal Peripartum Anti-TNFa Use on Infant Immune Response. Dig Dis Sci. 2016 06; 61(6):1622-7. PMID: 26725061.
      View in: PubMed
    11. Heris HK, Daoud J, Sheibani S, Vali H, Tabrizian M, Mongeau L. Investigation of the Viability, Adhesion, and Migration of Human Fibroblasts in a Hyaluronic Acid/Gelatin Microgel-Reinforced Composite Hydrogel for Vocal Fold Tissue Regeneration. Adv Healthc Mater. 2016 Jan 21; 5(2):255-65. PMID: 26501384.
      View in: PubMed
    12. Jones NK, Arab NT, Eid R, Gharib N, Sheibani S, Vali H, Khoury C, Murray A, Boucher E, Mandato CA, Young PG, Greenwood MT. Human Thyroid Cancer-1 (TC-1) is a vertebrate specific oncogenic protein that protects against copper and pro-apoptotic genes in yeast. Microb Cell. 2015 Jul 06; 2(7):247-255. PMID: 28357300.
      View in: PubMed
    13. Sheibani S, Jones NK, Eid R, Gharib N, Arab NT, Titorenko V, Vali H, Young PA, Greenwood MT. Inhibition of stress mediated cell death by human lactate dehydrogenase B in yeast. FEMS Yeast Res. 2015 Aug; 15(5):fov032. PMID: 26032856.
      View in: PubMed
    14. Mahmoudi M, Sheibani S, Milani AS, Rezaee F, Gauberti M, Dinarvand R, Vali H. Crucial role of the protein corona for the specific targeting of nanoparticles. Nanomedicine (Lond). 2015 Jan; 10(2):215-26. PMID: 25600967.
      View in: PubMed
    15. Kim JJ, Tsukamoto MM, Mathur AK, Ghomri YM, Hou LA, Sheibani S, Runyon BA. Delayed paracentesis is associated with increased in-hospital mortality in patients with spontaneous bacterial peritonitis. Am J Gastroenterol. 2014 Sep; 109(9):1436-42. PMID: 25091061.
      View in: PubMed
    16. Kim JJ, Sheibani S, Park S, Buxbaum J, Laine L. Causes of bleeding and outcomes in patients hospitalized with upper gastrointestinal bleeding. J Clin Gastroenterol. 2014 Feb; 48(2):113-8. PMID: 23685847.
      View in: PubMed
    17. Eid R, Sheibani S, Gharib N, Lapointe JF, Horowitz A, Vali H, Mandato CA, Greenwood MT. Human ribosomal protein L9 is a Bax suppressor that promotes cell survival in yeast. FEMS Yeast Res. 2014 May; 14(3):495-507. PMID: 24305165.
      View in: PubMed
    18. Sheibani S, Richard VR, Beach A, Leonov A, Feldman R, Mattie S, Khelghatybana L, Piano A, Greenwood M, Vali H, Titorenko VI. Macromitophagy, neutral lipids synthesis, and peroxisomal fatty acid oxidation protect yeast from "liponecrosis", a previously unknown form of programmed cell death. Cell Cycle. 2014; 13(1):138-47. PMID: 24196447.
      View in: PubMed
    19. Horowitz A, Lapointe JF, Eid R, Sheibani S, Gharib N, Jones NK, Vali H, Mandato CA, Greenwood MT. The human septin7 and the yeast CDC10 septin prevent Bax and copper mediated cell death in yeast. Biochim Biophys Acta. 2013 Dec; 1833(12):3186-3194. PMID: 24055994.
      View in: PubMed
    20. Sheibani S, Kim JJ, Chen B, Park S, Saberi B, Keyashian K, Buxbaum J, Laine L. Natural history of acute upper GI bleeding due to tumours: short-term success and long-term recurrence with or without endoscopic therapy. Aliment Pharmacol Ther. 2013 Jul; 38(2):144-50. PMID: 23710797.
      View in: PubMed
    21. Richard VR, Leonov A, Beach A, Burstein MT, Koupaki O, Gomez-Perez A, Levy S, Pluska L, Mattie S, Rafesh R, Iouk T, Sheibani S, Greenwood M, Vali H, Titorenko VI. Macromitophagy is a longevity assurance process that in chronologically aging yeast limited in calorie supply sustains functional mitochondria and maintains cellular lipid homeostasis. Aging (Albany NY). 2013 Apr; 5(4):234-69. PMID: 23553280.
      View in: PubMed
    22. Sheibani S, Mahadevan U. Editorial: Are thiopurines and anti-TNFa agents safe to use in pregnant patients with inflammatory bowel disease? Am J Gastroenterol. 2013 Mar; 108(3):441-3. PMID: 23459048.
      View in: PubMed
    23. Mahmoudi M, Quinlan-Pluck F, Monopoli MP, Sheibani S, Vali H, Dawson KA, Lynch I. Influence of the physiochemical properties of superparamagnetic iron oxide nanoparticles on amyloid ß protein fibrillation in solution. ACS Chem Neurosci. 2013 Mar 20; 4(3):475-85. PMID: 23509983.
      View in: PubMed
    24. Mahmoudi M, Saeedi-Eslami SN, Shokrgozar MA, Azadmanesh K, Hassanlou M, Kalhor HR, Burtea C, Rothen-Rutishauser B, Laurent S, Sheibani S, Vali H. Cell "vision": complementary factor of protein corona in nanotoxicology. Nanoscale. 2012 Sep 07; 4(17):5461-8. PMID: 22842341.
      View in: PubMed
    25. Clapp C, Portt L, Khoury C, Sheibani S, Norman G, Ebner P, Eid R, Vali H, Mandato CA, Madeo F, Greenwood MT. 14-3-3 protects against stress-induced apoptosis. Cell Death Dis. 2012 Jul 12; 3:e348. PMID: 22785534.
      View in: PubMed
    26. Clapp C, Portt L, Khoury C, Sheibani S, Eid R, Greenwood M, Vali H, Mandato CA, Greenwood MT. Untangling the Roles of Anti-Apoptosis in Regulating Programmed Cell Death using Humanized Yeast Cells. Front Oncol. 2012; 2:59. PMID: 22708116.
      View in: PubMed
    27. Rastegar SO, Mousavi SM, Shojaosadati SA, Sheibani S. Optimization of petroleum refinery effluent treatment in a UASB reactor using response surface methodology. J Hazard Mater. 2011 Dec 15; 197:26-32. PMID: 21983166.
      View in: PubMed
    28. Williams D, Norman G, Khoury C, Metcalfe N, Briard J, Laporte A, Sheibani S, Portt L, Mandato CA, Greenwood MT. Evidence for a second messenger function of dUTP during Bax mediated apoptosis of yeast and mammalian cells. Biochim Biophys Acta. 2011 Feb; 1813(2):315-21. PMID: 21145358.
      View in: PubMed
    29. Sheibani S, Levesque BG, Friedland S, Roost J, Gerson LB. Long-term impact of capsule endoscopy in patients referred for iron-deficiency anemia. Dig Dis Sci. 2010 Mar; 55(3):703-8. PMID: 19941072.
      View in: PubMed
    30. Sheibani S, Gerson LB. Chemical colitis. J Clin Gastroenterol. 2008 Feb; 42(2):115-21. PMID: 18209577.
      View in: PubMed
    31. Kahwaji CI, Sheibani S, Han S, Siu WO, Kaka AH, Fathy TM, el-Abbadi NH, Purdy RE. Evidence that simulated microgravity may alter the vascular nonreceptor tyrosine kinase second messenger pathway. Proc West Pharmacol Soc. 2000; 43:75-7. PMID: 11056962.
      View in: PubMed